TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells (Q34292924)

1 August 2017

title

TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells (English)

1 reference

1 August 2017

1 reference

M Haruta

1

1 reference

1 August 2017

Y Tomita

2

1 reference

1 August 2017

A Yuno

3

1 reference

1 August 2017

K Matsumura

4

1 reference

1 August 2017

T Ikeda

5

1 reference

1 August 2017

K Takamatsu

6

1 reference

1 August 2017

E Haga

7

1 reference

1 August 2017

C Koba

8

1 reference

1 August 2017

Y Nishimura

9

1 reference

1 August 2017

S Senju

10

1 reference

1 August 2017

publication date

9 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

20

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

504-513

1 reference

Dendritic cells as therapeutic agents against cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Presentation of tumour antigens by dendritic cells and challenges faced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Directed differentiation of dendritic cells from mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Homologous recombination in human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Cancer prevention with semi-allogeneic ES cell-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

The Myc/macrophage tango: oncogene-induced senescence, Myc style

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

Dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

7 January 2021

Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

7 January 2021

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

7 January 2021

CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2012.59

7 January 2021

Identifiers

DOI

10.1038/GT.2012.59

1 reference

1 August 2017

1 reference